No. PAR-25-311 · National Institutes of Health
Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)
No audit required
“This NOFO does not require cost sharing as defined in the NIH Grants Policy Statement Section 1.2 Definition of Terms .” — From the announcement
Not reimbursement-only
“Cooperative Agreement: A financial assistance mechanism used when there will be substantial Federal scientific or programmatic involvement.” — From the announcement
- Award range
- Up to $6,250,000
- Expected awards
- Not specified
- Application deadline
- Nov 15, 2027
- Posted
- Dec 16, 2024
- Last verified
- 9 days ago
At a glance
AI summaryThis program funds NICHD-supported, multisite clinical trials and observational studies for infants, children, women, including pregnant and lactating women, and persons with disabilities, using a two-phase UG3/UH3 award. It is open to a wide range of U.S. organizations, including nonprofits, universities, governments, tribal organizations, faith-based groups, and for-profit entities, but foreign organizations are not eligible. Applications must be investigator-initiated and use NICHD Network infrastructure, with some proposals needing a prior approved concept proposal. Direct costs are limited to $6,250,000 for the full project period, which can be up to 7 years total, with up to 2 years for UG3 and up to 5 years for UH3.
AI-generated summary — verify against the announcement
What it funds
Official description from grants.gov
The purpose of this Notice of Funding Opportunity (NOFO) is to leverage NICHD clinical research Network infrastructure relevant to infants, children, women, pregnant and lactating women, and persons with disabilities to conduct innovative, multisite, investigator-initiated clinical trials and observational studies. This NOFO will utilize a bi-phasic (UG3/UH3), milestone-driven mechanism consisting of a start-up phase (UG3) and a full enrollment and clinical trial implementation phase (UH3). Applications submitted in response to this NOFO must address specific aims and milestones for both the UG3 and UH3 phases. A UG3 project (phase I) that meets its milestones will be administratively considered by NICHD and prioritized for transition to the UH3 award (phase II). This NOFO provides an opportunity to leverage NICHD clinical research Network infrastructure as a platform for investigator-initiated innovative hypotheses by any investigator in the extramural community. Applications must be submitted as investigator-initiated, multi-Project Director/Principal Investigator (PD/PI) grant applications in conjunction with the respective NICHD-supported Network Data Coordinating Center (DCC), or equivalent as determined by the NICHD.
Who can apply
- City or township governments
- County governments
- For-profit organizations other than small businesses
- Independent school districts
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized)
- Nonprofits with 501(c)(3) status (other than higher education)
- Nonprofits without 501(c)(3) status (other than higher education)
- Others
- Private institutions of higher education
- Public and State controlled institutions of higher education
- Public housing authorities / Indian housing authorities
- Small businesses
- Special district governments
- State governments
Program history
USASpending.govAssistance listing 93.313 · NIH Office of Research on Women's Health
Real awards this federal program has made — the whole assistance listing (93.313), not just this notice.
No grants-family awards recorded for this program since FY 2021 — it may be new, renamed, or not yet reported to USASpending.
Source: USASpending.gov · refreshed Aug 30, 2026
Assistance listing 93.865 · Child Health and Human Development Extramural Research
Real awards this federal program has made — the whole assistance listing (93.865), not just this notice.
| Fiscal year | Awards | Median award | Middle half |
|---|---|---|---|
| FY 2026 (so far) | 386 | $392,826 | $79,188 – $593,582 |
| FY 2025 | 665 | $452,972 | $178,000 – $1,225,547 |
| FY 2024 | 785 | — | — |
| FY 2023 | 835 | — | — |
| FY 2022 | 799 | — | — |
| FY 2021 | 764 | — | — |
For comparison, this notice advertises Up to $6,250,000.
Dollar figures are based on the 1,000 most recent awards we store, not all 4,234 — award counts are complete.
- PRESIDENT AND FELLOWS OF HARVARD COLLEGE $16,115,056 · FY 2025
- UNIVERSITY OF MIAMI $15,385,183 · FY 2025
- UNIVERSITY OF WASHINGTON $6,635,347 · FY 2025
- GEORGE WASHINGTON UNIVERSITY (THE) $5,117,920 · FY 2025
- RESEARCH TRIANGLE INSTITUTE $4,847,747 · FY 2025
Source: USASpending.gov · refreshed Aug 23, 2026